scholarly article | Q13442814 |
P2093 | author name string | Qiuyun Chen | |
Lin Li | |||
Qinbo Yang | |||
Nancy Foldvary-Schaefer | |||
Qing Kenneth Wang | |||
William G Ondo | |||
P2860 | cites work | Components of a new human protein kinase signal transduction pathway | Q24319086 |
Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells | Q24522573 | ||
A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test | Q24538716 | ||
Sequence and structural analysis of BTB domain proteins | Q24812693 | ||
The TDT reveals linkage and linkage disequilibrium in a rare disease | Q28288684 | ||
Corl1, a novel neuronal lineage-specific transcriptional corepressor for the homeodomain transcription factor Lbx1 | Q28508618 | ||
Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome | Q31060091 | ||
Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p | Q33909864 | ||
Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. | Q34044826 | ||
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health | Q34273561 | ||
Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction | Q34319302 | ||
Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group | Q34370457 | ||
Autosomal dominant restless legs syndrome maps on chromosome 14q. | Q34533932 | ||
Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate | Q34564654 | ||
A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. | Q34565302 | ||
A genetic risk factor for periodic limb movements in sleep | Q34651669 | ||
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions | Q34653028 | ||
Autosomal-dominant locus for Restless Legs Syndrome in French-Canadians on chromosome 16p12.1. | Q34864009 | ||
The role of the MEIS homeobox genes in neuroblastoma | Q35184946 | ||
An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction | Q36430809 | ||
The role of iron in restless legs syndrome | Q36848436 | ||
Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis | Q37002338 | ||
Replication of restless legs syndrome loci in three European populations | Q37225625 | ||
MEIS1 p.R272H in familial restless legs syndrome | Q37274616 | ||
MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels | Q37292968 | ||
Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. | Q37376771 | ||
Family-based and population-based association studies validate PTPRD as a risk factor for restless legs syndrome | Q37492251 | ||
Proximodistal identity during vertebrate limb regeneration is regulated by Meis homeodomain proteins | Q38322021 | ||
Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. | Q40238140 | ||
Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies | Q41894157 | ||
Quantitative genetic analysis of ventral midbrain and liver iron in BXD recombinant inbred mice | Q44742607 | ||
Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome | Q46330968 | ||
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome | Q46460102 | ||
Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity | Q47411401 | ||
Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. | Q48454119 | ||
Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial | Q48735856 | ||
A randomized controlled study of pergolide in patients with restless legs syndrome | Q48768599 | ||
Restless legs syndrome improved by pramipexole: a double-blind randomized trial | Q48768649 | ||
A Genetic Risk Factor for Periodic Limb Movements in Sleep | Q57983245 | ||
Restless legs syndrome in monozygotic twins: clinical correlates | Q73213927 | ||
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome | Q73670387 | ||
A step forward for restless legs syndrome | Q80694619 | ||
Restless legs syndrome | Q84127539 | ||
P433 | issue | 8 | |
P921 | main subject | restless legs syndrome | Q916280 |
P1104 | number of pages | 5 | |
P304 | page(s) | 800-804 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | Sleep Medicine | Q15762248 |
P1476 | title | Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population | |
P478 | volume | 12 |
Q47751715 | Association of BTBD9 and MAP2K5/SKOR1 With Restless Legs Syndrome in Chinese Population |
Q37301849 | Association of restless legs syndrome variants in Korean patients with restless legs syndrome |
Q92957674 | Caenorhabditis elegans and its applicability to studies on restless legs syndrome |
Q36209401 | Genetic associations of periodic limb movements of sleep in the elderly for the MrOS sleep study |
Q61980338 | Genetics of Restless Legs Syndrome (RLS) |
Q34658391 | Genome-wide association studies in neurology |
Q48501616 | Haplotype Association of the MAP2K5 Gene with Antipsychotics-Induced Symptoms of Restless Legs Syndrome among Patients with Schizophrenia |
Q47695915 | Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations |
Q39150062 | Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome |
Q102388963 | Large genome-wide association study identifies three novel risk variants for restless legs syndrome |
Q54290859 | MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome. |
Q90265009 | MEIS1 and Restless Legs Syndrome: A Comprehensive Review |
Q41853935 | Neurological disorders: towards a mechanistic understanding of restless legs syndrome |
Q41586761 | New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder |
Q26740533 | Restless Legs Syndrome: Current Concepts about Disease Pathophysiology |
Q33753188 | Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management |
Q34335020 | Restless legs syndrome: pathophysiology and modern management |
Q91198675 | Rotigotine suppresses sleep-related muscle activity augmented by injection of dialysis patients' sera in a mouse model of restless legs syndrome |
Q96641016 | SKOR1 has a transcriptional regulatory role on genes involved in pathways related to restless legs syndrome |
Q39246948 | Sleep fragmentation and motor restlessness in a Drosophila model of Restless Legs Syndrome |
Q48069132 | Susceptible genes of restless legs syndrome in migraine |
Q44778403 | The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. |
Q27024585 | Treatment of restless legs syndrome |
Search more.